Fennec Pharmaceuticals (FENC) EBT Growth (3y) (2013 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 32.79% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 47.54% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -49.71% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 12.01% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 20.92% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -1.05% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 48.67% |
| 10 | Fennec Pharmaceuticals | 281.48 Mn | 244.70 Mn | 7.67 Mn | 32.33% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 32.33% |
| Sep 30, 2025 | 57.29% |
| Jun 30, 2025 | 14.55% |
| Mar 31, 2025 | 31.33% |
| Dec 31, 2024 | 29.35% |
| Sep 30, 2024 | -10.66% |
| Jun 30, 2024 | -12.07% |
| Mar 31, 2024 | 66.65% |
| Dec 31, 2023 | 7.73% |
| Sep 30, 2023 | 32.80% |
| Jun 30, 2023 | -3.65% |
| Mar 31, 2023 | -16.18% |
| Dec 31, 2022 | -23.35% |
| Sep 30, 2022 | -64.59% |
| Jun 30, 2022 | -2.45% |
| Mar 31, 2022 | -11.21% |
| Dec 31, 2021 | -12.49% |
| Sep 30, 2021 | -15.34% |
| Jun 30, 2021 | -14.76% |
| Mar 31, 2021 | -41.54% |
| Dec 31, 2020 | -10.18% |
| Sep 30, 2020 | -39.07% |
| Jun 30, 2020 | -48.51% |
| Mar 31, 2020 | -70.40% |
| Dec 31, 2019 | -46.32% |
| Sep 30, 2019 | -47.30% |
| Jun 30, 2019 | -88.34% |
| Mar 31, 2019 | -79.23% |
| Dec 31, 2018 | -75.73% |
| Sep 30, 2018 | -101.25% |
| Jun 30, 2018 | -66.85% |
| Mar 31, 2018 | -56.60% |
| Dec 31, 2017 | -46.66% |
| Sep 30, 2017 | -51.91% |
| Jun 30, 2017 | -16.55% |
| Mar 31, 2017 | -12.53% |
| Dec 31, 2016 | -39.99% |
| Sep 30, 2016 | -122.40% |
| Jun 30, 2016 | 8.86% |
| Mar 31, 2016 | 5.33% |
| Dec 31, 2015 | 20.84% |
| Sep 30, 2015 | 18.61% |
| Jun 30, 2015 | 23.51% |
| Mar 31, 2015 | 9.48% |
| Dec 31, 2014 | 3.82% |
| Sep 30, 2014 | 12.47% |
| Jun 30, 2014 | -17.56% |
| Mar 31, 2014 | 18.91% |
| Dec 31, 2013 | 19.69% |
| Sep 30, 2013 | 61.65% |
| Jun 30, 2013 | 28.05% |